TSLA Tesla, Inc.
Motor Vehicles & Passenger Car Bodies · Nasdaq · SEC CIK 1318605 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.3%
TTM net income YoY-38.9%
TTM EPS YoY-37.2%
Revenue 3-yr CAGR2.6%
Net income 3-yr CAGR-33.1%
Margins
Gross margin19.3%
Operating margin3.3%
Net margin3.1%
FCF margin3.2%
EBITDA margin8.8%
Returns
ROE3.8%
ROA2.2%
ROIC (approx.)3.6%
Asset turnover0.71x
Leverage & solvency
Liabilities / assets42.9%
Debt / equity0.10x
Current ratio1.74x
Interest coverage9.96x
Cash quality & payout
Operating cash flow / net income5.81x
Accruals ratio-10.6%
Payout ratio—
Capex / revenue14.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $28.05B | $28.24B | $22.39B | $24.90B | $28.09B | $22.50B | $19.34B | $25.71B |
| Cost of revenue | $22.55B | $23.48B | $17.67B | $19.89B | $23.04B | $18.62B | $16.18B | $21.53B |
| Gross profit | $5.49B | $4.75B | $4.72B | $5.01B | $5.05B | $3.88B | $3.15B | $4.18B |
| R&D expense | $2.76B | $2.37B | $1.95B | $1.78B | $1.63B | $1.59B | $1.41B | $1.28B |
| SG&A expense | $2.02B | $1.98B | $1.83B | $1.66B | $1.56B | $1.37B | $1.25B | $1.31B |
| Operating income | $718.00M | $398.00M | $941.00M | $1.41B | $1.62B | $923.00M | $399.00M | $1.58B |
| Interest expense | $90.00M | $81.00M | $92.00M | $85.00M | $76.00M | $86.00M | $91.00M | $96.00M |
| Pretax income | $956.00M | $1.33B | $748.00M | $1.18B | $1.96B | $1.55B | $589.00M | $2.52B |
| Income tax | $152.00M | $201.00M | $257.00M | $325.00M | $570.00M | $359.00M | $169.00M | $434.00M |
| Net income | $787.00M | $1.11B | $477.00M | $840.00M | $1.37B | $1.17B | $409.00M | $2.32B |
| EBITDA | $2.30B | $1.77B | $2.28B | $2.79B | $2.97B | $2.07B | $1.55B | $2.74B |
| EPS (basic) | 0.24 | 0.34 | 0.15 | — | 0.43 | 0.36 | 0.13 | — |
| EPS (diluted) | 0.22 | 0.32 | 0.13 | — | 0.39 | 0.33 | 0.12 | — |
| Weighted avg. shares (diluted) | 3.54B | 3.54B | 3.54B | — | 3.53B | 3.52B | 3.52B | — |
| Balance sheet | ||||||||
| Cash & equivalents | $17.85B | $15.22B | $16.60B | $16.51B | $18.29B | $15.59B | $16.35B | $16.14B |
| Short-term investments | $27.59B | $28.30B | $28.14B | $27.55B | $23.36B | $21.20B | $20.64B | $20.42B |
| Receivables | $4.64B | $4.09B | $3.96B | $4.58B | $4.70B | $3.84B | $3.78B | $4.42B |
| Inventory | $14.09B | $13.75B | $14.43B | $12.39B | $12.28B | $14.57B | $13.71B | $12.02B |
| Current assets | $70.40B | $68.76B | $69.75B | $68.64B | $64.65B | $61.13B | $59.39B | $58.36B |
| PP&E, net | $50.59B | $47.26B | $43.21B | $40.64B | $39.41B | $38.57B | $37.09B | $35.84B |
| Goodwill | — | — | — | $257.00M | $257.00M | $258.00M | $248.00M | $244.00M |
| Intangibles | — | — | — | $124.00M | $131.00M | $138.00M | $144.00M | $150.00M |
| Total assets | $157.52B | $148.52B | $143.72B | $137.81B | $133.74B | $128.57B | $125.11B | $122.07B |
| Current liabilities | $40.49B | $35.42B | $34.14B | $31.71B | $31.29B | $30.01B | $29.75B | $28.82B |
| Short-term debt | $1.31B | $1.34B | $1.37B | $1.57B | $1.85B | $1.96B | $2.16B | $2.34B |
| Long-term debt | $7.96B | $7.72B | $7.64B | $6.58B | $5.61B | $4.99B | $5.08B | $5.54B |
| Total debt | $9.27B | $9.06B | $9.02B | $8.15B | $7.46B | $6.96B | $7.24B | $7.88B |
| Total liabilities | $67.63B | $61.01B | $58.92B | $54.94B | $53.02B | $50.49B | $49.69B | $48.39B |
| Shareholders' equity | $89.29B | $86.86B | $84.12B | $82.14B | $79.97B | $77.31B | $74.65B | $72.91B |
| Net debt | -$8.59B | -$6.16B | -$7.58B | -$8.36B | -$10.83B | -$8.63B | -$9.11B | -$8.26B |
| Shares outstanding | 3.95B | 3.95B | 3.75B | 3.75B | 3.32B | 3.22B | 3.22B | 3.22B |
| Cash flow statement | ||||||||
| Operating cash flow | $6.26B | $4.70B | $3.94B | $3.81B | $6.24B | $2.54B | $2.16B | $4.81B |
| Capital expenditure | $4.73B | $5.79B | $2.49B | $2.39B | $2.25B | $2.39B | $1.49B | $2.78B |
| Free cash flow | $1.53B | -$1.09B | $1.44B | $1.42B | $3.99B | $146.00M | $664.00M | $2.03B |
| Investing cash flow | -$3.98B | -$5.93B | -$5.02B | -$6.53B | -$4.36B | -$2.94B | -$1.65B | -$7.60B |
| Financing cash flow | $327.00M | $37.00M | $1.17B | $710.00M | $983.00M | -$222.00M | -$332.00M | $985.00M |
| Depreciation & amortization | $1.58B | $1.37B | $1.34B | $1.38B | $1.35B | $1.15B | $1.15B | $1.16B |
| Stock-based compensation | $1.17B | $1.15B | $1.03B | $954.00M | $663.00M | $635.00M | $573.00M | $579.00M |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.